Digoxin

Generic name: Pronounced as (di jox' in)
Brand names
  • Cardoxin®
  • Digitek®
  • Lanoxicaps®
  • Lanoxin®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 06/15/2017

Digoxin is used to treat heart failure and abnormal heart rhythms (arrhythmias). It helps the heart work better and it helps control your heart rate.

Digoxin comes as a tablet, capsule, or pediatric elixir (liquid) to take by mouth. Digoxin is usually taken once a day. The pediatric elixir comes with a specially marked dropper for measuring the dose. If you have difficulty, ask your pharmacist to show you how to use it. It is important that you always take the same brand of digoxin. Different brands of digoxin have different amounts of active drug and your dose would need to be changed.

Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take digoxin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Digoxin helps control your condition but will not cure it. Continue to take digoxin even if you feel well. Do not stop taking digoxin without talking to your doctor.

Digoxin is also used to treat heart pain (angina) and may be used after a heart attack. Talk to your doctor about the possible risks of using this drug for your condition.

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Before taking digoxin,

  • tell your doctor and pharmacist if you are allergic to digoxin, digitoxin, or any other drugs.

  • tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially antacids, antibiotics, calcium, corticosteroids, diuretics ('water pills'), other medications for heart disease, thyroid medications, and vitamins.

  • tell your doctor if you have or have ever had thyroid problems, heart arrhythmias, cancer, or kidney disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking digoxin, call your doctor.

  • talk to your doctor about the risks and benefits of taking this medication if you are 65 years of age or older. Older adults should usually receive low doses of digoxin because higher doses may cause serious side effects.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking digoxin.

  • you should know that this medication may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.

  • remember that alcohol can add to the drowsiness caused by this medication.

Your doctor may recommend a low-sodium (low-salt) diet and a potassium supplement. Ask your pharmacist or doctor for a list of foods that are low in sodium and high in potassium. Follow all diet directions carefully.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Digoxin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • dizziness or lightheadedness

    • drowsiness

    • vision changes (blurred or yellow)

    • rash

    • irregular heartbeat

  • Some side effects may be serious. If you experience any of the following symptoms, call your doctor immediately:

    • upset stomach

    • vomiting

    • diarrhea

    • loss of appetite

    • swelling of the feet or hands

    • unusual weight gain

    • difficulty breathing

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor will need to determine your response to digoxin. You may have electrocardiograms (EKGs) and blood tests periodically, and your dose may need to be adjusted. Your doctor may ask you to check your pulse (heart rate). Ask your pharmacist or doctor to teach you how to take your pulse. If your pulse is faster or slower than it should be, call your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Moxifloxacin.
Repaglinide Repaglinide Repaglinide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Atorvastatin Atorvastatin The serum concentration of Digoxin can be increased when it is combined with Atorvastatin.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Digoxin is combined with Dolasetron.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Digoxin is combined with Anagrelide.
Calcium Carbonate Calcium Carbonate Calcium carbonate may increase the arrhythmogenic activities of Digoxin.
Candesartan Candesartan The excretion of Digoxin can be decreased when combined with Candesartan.
Cilostazol Cilostazol Cilostazol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Diphenoxylate Diphenoxylate The serum concentration of Digoxin can be increased when it is combined with Diphenoxylate.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The serum concentration of Digoxin can be increased when it is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fenofibrate Fenofibrate Digoxin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine Guanfacine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Magnesium Hydroxide Magnesium Hydroxide Magnesium hydroxide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Magnesium Oxide Magnesium Oxide The serum concentration of Digoxin can be decreased when it is combined with Magnesium oxide.
Miglitol Miglitol The serum concentration of Digoxin can be decreased when it is combined with Miglitol.
Mycophenolate Mycophenolate Mycophenolic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Paregoric Paregoric The serum concentration of Digoxin can be increased when it is combined with Morphine.
Penbutolol Penbutolol Acebutolol may increase the arrhythmogenic activities of Digoxin.
Polyethylene glycol-electrolyte solution (PEG-ES) Polyethylene glycol-electrolyte solution (PEG-ES) The serum concentration of Digoxin can be decreased when it is combined with Polyethylene glycol.
Potassium Potassium Digoxin may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Digoxin.
Ranitidine Ranitidine Digoxin may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Digoxin.
Rizatriptan Rizatriptan Rizatriptan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sumatriptan Sumatriptan Sumatriptan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tacrolimus Tacrolimus Tacrolimus may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Tizanidine.
Triamcinolone Triamcinolone The risk or severity of hypokalemia can be increased when Triamcinolone is combined with Digoxin.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Famotidine.
Fluconazole Injection Fluconazole Injection Fluconazole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Digoxin which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection Digoxin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection Digoxin may decrease the excretion rate of Meperidine which could result in a higher serum level.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Digoxin.
Metoclopramide Injection Metoclopramide Injection The serum concentration of Digoxin can be decreased when it is combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Metronidazole.
Morphine Injection Morphine Injection The serum concentration of Digoxin can be increased when it is combined with Morphine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Vancomycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Altretamine Altretamine Amphetamine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cyclosporine Cyclosporine The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Digoxin is combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Digoxin is combined with Enoxaparin.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Digoxin is combined with Granisetron.
Olanzapine Olanzapine The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Digoxin.
Dofetilide Dofetilide The risk or severity of torsade de pointes can be increased when Dofetilide is combined with Digoxin.
Eprosartan Eprosartan The risk or severity of hyperkalemia can be increased when Digoxin is combined with Eprosartan.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Hydroxychloroquine.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sevelamer Sevelamer Sevelamer can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan Telmisartan The serum concentration of Digoxin can be increased when it is combined with Telmisartan.
Temozolomide Temozolomide Temozolomide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Zaleplon Zaleplon Zaleplon may decrease the excretion rate of Digoxin which could result in a higher serum level.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Desloratadine.
Rivastigmine Rivastigmine Digoxin may increase the bradycardic activities of Rivastigmine.
Trimipramine Trimipramine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Trimipramine.
Glycopyrrolate Glycopyrrolate The serum concentration of Digoxin can be increased when it is combined with Glycopyrronium.
Perindopril Perindopril Perindopril may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sirolimus Sirolimus The serum concentration of Digoxin can be increased when it is combined with Sirolimus.
Epinephrine Injection Epinephrine Injection The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Digoxin.
Epirubicin Epirubicin Epirubicin may decrease the cardiotoxic activities of Digoxin.
Eplerenone Eplerenone Eplerenone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Escitalopram Escitalopram The risk or severity of QTc prolongation can be increased when Digoxin is combined with Escitalopram.
Zonisamide Zonisamide Zonisamide may increase the arrhythmogenic activities of Digoxin.
Aripiprazole Aripiprazole The risk or severity of QTc prolongation can be increased when Digoxin is combined with Aripiprazole.
Atomoxetine Atomoxetine Atomoxetine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ezetimibe Ezetimibe Ezetimibe may decrease the excretion rate of Digoxin which could result in a higher serum level.
Teriparatide Injection Teriparatide Injection The risk or severity of adverse effects can be increased when Teriparatide is combined with Digoxin.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Almotriptan Almotriptan Almotriptan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Digoxin.
Polyethylene Glycol 3350 Polyethylene Glycol 3350 The serum concentration of Digoxin can be decreased when it is combined with Polyethylene glycol.
Rosuvastatin Rosuvastatin Rosuvastatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vardenafil Vardenafil Vardenafil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Alfuzosin Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Digoxin.
Emtricitabine Emtricitabine Digoxin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Memantine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tegaserod Tegaserod The serum concentration of Digoxin can be increased when it is combined with Tegaserod.
Tadalafil Tadalafil Tadalafil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Gemifloxacin.
Progesterone Progesterone Progesterone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Apomorphine.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Digoxin.
Duloxetine Duloxetine Digoxin may decrease the excretion rate of Duloxetine which could result in a higher serum level.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bosentan Bosentan Bosentan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Erlotinib Erlotinib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Erlotinib.
Eszopiclone Eszopiclone Eszopiclone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Digoxin is combined with Solifenacin.
Valganciclovir Valganciclovir Valganciclovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Voriconazole Voriconazole The risk or severity of QTc prolongation can be increased when Digoxin is combined with Voriconazole.
Adefovir Adefovir Adefovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection Digoxin may decrease the cardiotoxic activities of Peginterferon alfa-2a.
Exenatide Injection Exenatide Injection The serum concentration of Digoxin can be decreased when it is combined with Exenatide.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Digoxin is combined with Ibandronate.
Ramelteon Ramelteon Ramelteon may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fentanyl Fentanyl Digoxin may decrease the excretion rate of Fentanyl which could result in a higher serum level.
Pregabalin Pregabalin Pregabalin may increase the arrhythmogenic activities of Digoxin.
Tipranavir Tipranavir Tipranavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Digoxin is combined with Felbamate.
Rasagiline Rasagiline Rasagiline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Imatinib Imatinib Digoxin may decrease the excretion rate of Imatinib which could result in a higher serum level.
Sitagliptin Sitagliptin Sitagliptin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Varenicline Varenicline Varenicline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bevacizumab Injection Bevacizumab Injection Digoxin may decrease the cardiotoxic activities of Bevacizumab.
Albuterol Albuterol The serum concentration of Digoxin can be decreased when it is combined with Salbutamol.
Paliperidone Paliperidone Paliperidone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bortezomib Bortezomib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Clofarabine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lubiprostone Lubiprostone Lubiprostone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Oxaliplatin.
Posaconazole Posaconazole The serum concentration of Digoxin can be increased when it is combined with Posaconazole.
Primaquine Primaquine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Primaquine.
Aliskiren Aliskiren The risk or severity of hyperkalemia can be increased when Digoxin is combined with Aliskiren.
Bismuth Subsalicylate Bismuth Subsalicylate The serum concentration of Digoxin can be decreased when it is combined with Bismuth subsalicylate.
Darunavir Darunavir The excretion of Digoxin can be decreased when combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection Digoxin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Digoxin is combined with Dimenhydrinate.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Digoxin is combined with Vorinostat.
Sorafenib Sorafenib Sorafenib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sunitinib Sunitinib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Sunitinib.
Lapatinib Lapatinib The bioavailability of Digoxin can be increased when combined with Lapatinib.
Levocetirizine Levocetirizine Levocetirizine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Pegaptanib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dasatinib Dasatinib The serum concentration of Digoxin can be increased when it is combined with Dasatinib.
Mexiletine Mexiletine Mexiletine may increase the arrhythmogenic activities of Digoxin.
Azacitidine Injection Azacitidine Injection Azacitidine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ivermectin Ivermectin The excretion of Digoxin can be decreased when combined with Ivermectin.
Temsirolimus Temsirolimus The serum concentration of Digoxin can be increased when it is combined with Temsirolimus.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nilotinib Nilotinib Nilotinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Toremifene Toremifene Toremifene may decrease the excretion rate of Digoxin which could result in a higher serum level.
Budesonide Budesonide The risk or severity of adverse effects can be increased when Budesonide is combined with Digoxin.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Doripenem Injection Doripenem Injection Doripenem may decrease the excretion rate of Digoxin which could result in a higher serum level.
Etravirine Etravirine The serum concentration of Digoxin can be increased when it is combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection Digoxin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Mitoxantrone Injection Mitoxantrone Injection Digoxin may decrease the cardiotoxic activities of Mitoxantrone.
Desvenlafaxine Desvenlafaxine Desvenlafaxine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nebivolol Nebivolol Nebivolol may increase the arrhythmogenic activities of Digoxin.
Tretinoin Tretinoin Digoxin may decrease the cardiotoxic activities of Tretinoin.
Bendamustine Injection Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Digoxin.
Flecainide Flecainide The serum concentration of Digoxin can be increased when it is combined with Flecainide.
Certolizumab Injection Certolizumab Injection Certolizumab pegol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ixabepilone Injection Ixabepilone Injection The serum concentration of Digoxin can be increased when it is combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The excretion of Digoxin can be decreased when combined with Irinotecan.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Methylnaltrexone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Silodosin Silodosin The serum concentration of Digoxin can be increased when it is combined with Silodosin.
Midazolam Midazolam Midazolam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Digoxin which could result in a higher serum level.
Eltrombopag Eltrombopag The excretion of Digoxin can be decreased when combined with Eltrombopag.
Milnacipran Milnacipran The risk or severity of hypotension can be increased when Milnacipran is combined with Digoxin.
Plerixafor Injection Plerixafor Injection Plerixafor may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate Sodium phosphate, monobasic may increase the hyperkalemic activities of Digoxin.
Fesoterodine Fesoterodine Fesoterodine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Degarelix.
Betaxolol Betaxolol Betaxolol may increase the arrhythmogenic activities of Digoxin.
Iloperidone Iloperidone The risk or severity of QTc prolongation can be increased when Digoxin is combined with Iloperidone.
Prasugrel Prasugrel Prasugrel may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lacosamide Lacosamide Digoxin may increase the bradycardic activities of Lacosamide.
Everolimus Everolimus The serum concentration of Digoxin can be increased when it is combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The serum concentration of Digoxin can be increased when it is combined with Tolvaptan.
Dronedarone Dronedarone Digoxin may increase the atrioventricular blocking (AV block) activities of Dronedarone.
Pralatrexate Injection Pralatrexate Injection Pralatrexate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Digoxin which could result in a higher serum level.
Saxagliptin Saxagliptin Saxagliptin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Telavancin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Romidepsin.
Topotecan Topotecan Topotecan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pazopanib Pazopanib The serum concentration of Digoxin can be increased when it is combined with Pazopanib.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Asenapine.
Pitavastatin Pitavastatin Pitavastatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dalfampridine Dalfampridine Dalfampridine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fingolimod Fingolimod Digoxin may increase the bradycardic activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The serum concentration of Digoxin can be increased when it is combined with Cabazitaxel.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Digoxin is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vilazodone Vilazodone The serum concentration of Digoxin can be increased when it is combined with Vilazodone.
Ipilimumab Injection Ipilimumab Injection Ipilimumab may decrease the excretion rate of Digoxin which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Terbutaline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Azilsartan Azilsartan The risk or severity of hyperkalemia can be increased when Digoxin is combined with Azilsartan medoxomil.
Busulfan Injection Busulfan Injection Digoxin may decrease the cardiotoxic activities of Busulfan.
Roflumilast Roflumilast Roflumilast may decrease the excretion rate of Digoxin which could result in a higher serum level.
Linagliptin Linagliptin Linagliptin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Rilpivirine Rilpivirine The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Digoxin.
Telaprevir Telaprevir Glecaprevir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Potassium Iodide Potassium Iodide The serum concentration of Digoxin can be increased when it is combined with Potassium Iodide.
Cyclophosphamide Injection Cyclophosphamide Injection Digoxin may decrease the cardiotoxic activities of Cyclophosphamide.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Triptorelin.
Rivaroxaban Rivaroxaban Rivaroxaban may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ticagrelor Ticagrelor The serum concentration of Digoxin can be increased when it is combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Digoxin.
Ruxolitinib Ruxolitinib Ruxolitinib may increase the bradycardic activities of Digoxin.
Vandetanib Vandetanib Vandetanib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Clobazam Clobazam Clobazam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vemurafenib Vemurafenib The serum concentration of Digoxin can be increased when it is combined with Vemurafenib.
Ivacaftor Ivacaftor Ivacaftor may decrease the excretion rate of Digoxin which could result in a higher serum level.
Deferiprone Deferiprone Deferiprone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Axitinib Axitinib The serum concentration of Axitinib can be increased when it is combined with Digoxin.
Crizotinib Crizotinib Crizotinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cabergoline Cabergoline The serum concentration of Cabergoline can be increased when it is combined with Digoxin.
Naloxone Injection Naloxone Injection Naloxone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ambrisentan Ambrisentan The serum concentration of Ambrisentan can be increased when it is combined with Digoxin.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pertuzumab Injection Pertuzumab Injection Digoxin may decrease the cardiotoxic activities of Pertuzumab.
Carfilzomib Injection Carfilzomib Injection Digoxin may decrease the excretion rate of Carfilzomib which could result in a higher serum level.
Enzalutamide Enzalutamide Enzalutamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Mirabegron Mirabegron Mirabegron may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bosutinib Bosutinib The serum concentration of Bosutinib can be increased when it is combined with Digoxin.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Corticotropin is combined with Digoxin.
Teriflunomide Teriflunomide The excretion of Digoxin can be decreased when combined with Teriflunomide.
Teduglutide Injection Teduglutide Injection Teduglutide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Digoxin is combined with Bedaquiline.
Tofacitinib Tofacitinib Digoxin may increase the bradycardic activities of Tofacitinib.
Alogliptin Alogliptin Alogliptin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ponatinib Ponatinib Ponatinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pomalidomide Pomalidomide Pomalidomide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The serum concentration of Digoxin can be increased when it is combined with Trastuzumab emtansine.
Apixaban Apixaban The serum concentration of Digoxin can be increased when it is combined with Apixaban.
Canagliflozin Canagliflozin The serum concentration of Digoxin can be increased when it is combined with Canagliflozin.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The serum concentration of Digoxin can be increased when it is combined with Dabrafenib.
Trametinib Trametinib Trametinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dolutegravir Dolutegravir The serum concentration of Digoxin can be increased when it is combined with Dolutegravir.
Afatinib Afatinib Afatinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Levomilnacipran Levomilnacipran The risk or severity of hypotension can be increased when Levomilnacipran is combined with Digoxin.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tigecycline Injection Tigecycline Injection Tigecycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Vortioxetine Vortioxetine Vortioxetine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lomitapide Lomitapide Lomitapide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Digoxin which could result in a higher serum level.
Simeprevir Simeprevir Simeprevir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sofosbuvir Sofosbuvir Sofosbuvir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dapagliflozin Dapagliflozin Dapagliflozin may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast Apremilast Apremilast may decrease the excretion rate of Digoxin which could result in a higher serum level.
Droxidopa Droxidopa Droxidopa may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ceritinib Ceritinib Digoxin may increase the bradycardic activities of Ceritinib.
Belinostat Injection Belinostat Injection The serum concentration of Digoxin can be increased when it is combined with Belinostat.
Idelalisib Idelalisib The serum concentration of Digoxin can be increased when it is combined with Idelalisib.
Testosterone Injection Testosterone Injection Digoxin may decrease the excretion rate of Testosterone which could result in a higher serum level.
Vorapaxar Vorapaxar Vorapaxar may decrease the excretion rate of Digoxin which could result in a higher serum level.
Suvorexant Suvorexant Suvorexant may decrease the excretion rate of Digoxin which could result in a higher serum level.
Edoxaban Edoxaban Edoxaban may decrease the excretion rate of Digoxin which could result in a higher serum level.
Caspofungin Injection Caspofungin Injection The excretion of Caspofungin can be decreased when combined with Digoxin.
Methamphetamine Methamphetamine Metamfetamine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tasimelteon Tasimelteon Tasimelteon may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lanreotide Injection Lanreotide Injection Digoxin may increase the bradycardic activities of Lanreotide.
Nintedanib Nintedanib The serum concentration of Digoxin can be increased when it is combined with Nintedanib.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Risperidone.
Palbociclib Palbociclib Palbociclib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lenvatinib Lenvatinib Lenvatinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Panobinostat Panobinostat The serum concentration of Digoxin can be increased when it is combined with Panobinostat.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Haloperidol.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Ivabradine Ivabradine Ivabradine may increase the bradycardic activities of Digoxin.
Amiloride Amiloride Amiloride may decrease the excretion rate of Digoxin which could result in a higher serum level.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Digoxin can be increased when it is combined with Isavuconazonium.
Macitentan Macitentan Macitentan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Flibanserin Flibanserin Flibanserin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Rolapitant Rolapitant Rolapitant may decrease the excretion rate of Digoxin which could result in a higher serum level.
Prednisolone Prednisolone The risk or severity of adverse effects can be increased when Prednisolone is combined with Digoxin.
Daclatasvir Daclatasvir Daclatasvir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Ziprasidone.
Penicillin G Procaine Injection Penicillin G Procaine Injection Procaine benzylpenicillin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Eluxadoline Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Digoxin.
Cobimetinib Cobimetinib The serum concentration of Cobimetinib can be increased when it is combined with Digoxin.
Osimertinib Osimertinib The serum concentration of Digoxin can be increased when it is combined with Osimertinib.
Ixazomib Ixazomib Ixazomib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lesinurad Lesinurad Lesinurad may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Digoxin.
Dexamethasone Injection Dexamethasone Injection The risk or severity of adverse effects can be increased when Dexamethasone is combined with Digoxin.
Brivaracetam Injection Brivaracetam Injection Brivaracetam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Venetoclax Venetoclax Venetoclax may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cobicistat Cobicistat Cobicistat may decrease the excretion rate of Digoxin which could result in a higher serum level.
Midodrine Midodrine Digoxin may increase the bradycardic, atrioventricular blocking (AV block), and arrhythmogenic activities of Midodrine.
Selexipag Selexipag The serum concentration of Selexipag can be increased when it is combined with Digoxin.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Diphenhydramine.
Calcifediol Calcifediol The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Calcifediol is combined with Digoxin.
Ergocalciferol Ergocalciferol The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Ergocalciferol is combined with Digoxin.
Doxercalciferol Doxercalciferol The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Doxercalciferol is combined with Digoxin.
Furosemide Injection Furosemide Injection The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.
Rucaparib Rucaparib Rucaparib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lixisenatide Injection Lixisenatide Injection Lixisenatide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Ribociclib.
Parathyroid Hormone Injection Parathyroid Hormone Injection The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Digoxin.
Doxepin (Insomnia) Doxepin (Insomnia) Digoxin may decrease the excretion rate of Doxepin which could result in a higher serum level.
Deutetrabenazine Deutetrabenazine Digoxin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Valbenazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Deflazacort Deflazacort The risk or severity of adverse effects can be increased when Deflazacort is combined with Digoxin.
Naldemedine Naldemedine Naldemedine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Neratinib Neratinib Neratinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Enasidenib Enasidenib Enasidenib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Digoxin can be increased when it is combined with Inotuzumab ozogamicin.
Benznidazole Benznidazole Benznidazole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The serum concentration of Digoxin can be increased when it is combined with Copanlisib.
Delafloxacin Delafloxacin Delafloxacin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Abemaciclib Abemaciclib The serum concentration of Abemaciclib can be increased when it is combined with Digoxin.
Betrixaban Betrixaban The serum concentration of Digoxin can be increased when it is combined with Betrixaban.
Letermovir Letermovir Digoxin may decrease the excretion rate of Letermovir which could result in a higher serum level.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The serum concentration of Digoxin can be increased when it is combined with Ertugliflozin.
Apalutamide Apalutamide The serum concentration of Digoxin can be decreased when it is combined with Apalutamide.
Penicillamine Penicillamine The serum concentration of Digoxin can be decreased when it is combined with Penicillamine.
Avatrombopag Avatrombopag The serum concentration of Digoxin can be increased when it is combined with Avatrombopag.
Baricitinib Baricitinib Baricitinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lofexidine Lofexidine Lofexidine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Plazomicin Injection Plazomicin Injection Plazomicin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Eliglustat Eliglustat The serum concentration of Digoxin can be increased when it is combined with Eliglustat.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Encorafenib.
Binimetinib Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Digoxin.
Ivosidenib Ivosidenib Ivosidenib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lusutrombopag Lusutrombopag The serum concentration of Digoxin can be increased when it is combined with Lusutrombopag.
Elagolix Elagolix Digoxin may decrease the excretion rate of Elagolix which could result in a higher serum level.
Eravacycline Injection Eravacycline Injection Eravacycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Tafenoquine Tafenoquine The serum concentration of Digoxin can be increased when it is combined with Tafenoquine.
Dacomitinib Dacomitinib Dacomitinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Duvelisib Duvelisib The serum concentration of Digoxin can be increased when it is combined with Duvelisib.
Omadacycline Omadacycline Omadacycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Sarecycline Sarecycline Sarecycline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Stiripentol Stiripentol Stiripentol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Talazoparib Talazoparib The serum concentration of Digoxin can be increased when it is combined with Talazoparib.
Gilteritinib Gilteritinib The serum concentration of Digoxin can be increased when it is combined with Gilteritinib.
Glasdegib Glasdegib Glasdegib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Larotrectinib Larotrectinib The serum concentration of Digoxin can be increased when it is combined with Larotrectinib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection Paclitaxel may decrease the excretion rate of Digoxin which could result in a higher serum level.
Rifamycin Rifamycin Rifamycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Prucalopride Prucalopride Prucalopride may decrease the excretion rate of Digoxin which could result in a higher serum level.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Erdafitinib Erdafitinib The serum concentration of Digoxin can be increased when it is combined with Erdafitinib.
Esomeprazole Injection Esomeprazole Injection The serum concentration of Digoxin can be increased when it is combined with Esomeprazole.
Cladribine Cladribine Digoxin may decrease the cardiotoxic activities of Cladribine.
Solriamfetol Solriamfetol Solriamfetol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Darolutamide Darolutamide The serum concentration of Digoxin can be increased when it is combined with Darolutamide.
Triclabendazole Triclabendazole The risk or severity of QTc prolongation can be increased when Digoxin is combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Digoxin is combined with Entrectinib.
Pexidartinib Pexidartinib The excretion of Digoxin can be decreased when combined with Pexidartinib.
Istradefylline Istradefylline The serum concentration of Digoxin can be increased when it is combined with Istradefylline.
Pitolisant Pitolisant Pitolisant may increase the QTc-prolonging activities of Digoxin.
Fedratinib Fedratinib Digoxin may decrease the excretion rate of Fedratinib which could result in a higher serum level.
Lefamulin Lefamulin Digoxin may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection Phenytoin Injection The serum concentration of Digoxin can be decreased when it is combined with Phenytoin.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Digoxin can be increased when it is combined with Enfortumab vedotin.
Lasmiditan Lasmiditan The serum concentration of Digoxin can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Digoxin can be increased when it is combined with Ubrogepant.
Calcium Acetate Calcium Acetate Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Digoxin.
Tazemetostat Tazemetostat The serum concentration of Digoxin can be increased when it is combined with Tazemetostat.
Bempedoic Acid Bempedoic Acid The excretion of Digoxin can be decreased when combined with Bempedoic acid.
Selumetinib Selumetinib The serum concentration of Digoxin can be increased when it is combined with Selumetinib.
Rimegepant Rimegepant The serum concentration of Digoxin can be increased when it is combined with Rimegepant.
Tucatinib Tucatinib Tucatinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Remdesivir Injection Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Digoxin.
Ripretinib Ripretinib Ripretinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Capmatinib Capmatinib The serum concentration of Digoxin can be increased when it is combined with Capmatinib.
Lemborexant Lemborexant The serum concentration of Digoxin can be increased when it is combined with Lemborexant.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Digoxin is combined with Fostemsavir.
Octreotide Octreotide The serum concentration of Digoxin can be decreased when it is combined with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Digoxin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Digoxin is combined with Relugolix.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Digoxin may increase the excretion rate of Drospirenone which could result in a lower serum level and potentially a reduction in efficacy.
Vibegron Vibegron The serum concentration of Digoxin can be increased when it is combined with Vibegron.
Viloxazine Viloxazine Viloxazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Indomethacin Indomethacin The serum concentration of Digoxin can be increased when it is combined with Indomethacin.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Digoxin which could result in a higher serum level.
Trazodone Trazodone The serum concentration of Digoxin can be increased when it is combined with Trazodone.
Isotretinoin Isotretinoin Digoxin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Bicarbonate Sodium Bicarbonate The serum concentration of Digoxin can be decreased when it is combined with Sodium bicarbonate.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Phenobarbital Phenobarbital Phenobarbital may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Metaxalone Metaxalone Metaxalone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methsuximide Methsuximide Methsuximide may increase the arrhythmogenic activities of Digoxin.
Chlorpromazine Chlorpromazine Chlorpromazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Diazepam Diazepam Diazepam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Oxazepam Oxazepam Oxazepam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Flurazepam Flurazepam Digoxin may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Clorazepic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Lorazepam Lorazepam Lorazepam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Carmustine Carmustine Carmustine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amantadine Amantadine Amantadine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Codeine Codeine Codeine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Phenelzine Phenelzine Phenelzine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tetracycline Tetracycline The serum concentration of Digoxin can be increased when it is combined with Tetracycline.
Minocycline Minocycline Minocycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Demeclocycline Demeclocycline Demeclocycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Prochlorperazine.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Thioridazine.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sulfadiazine Sulfadiazine Sulfadiazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methadone Methadone Methadone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Benztropine Benztropine Benzatropine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Colestipol Colestipol The serum concentration of Digoxin can be decreased when it is combined with Colestipol.
Maprotiline Maprotiline Maprotiline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ibuprofen Ibuprofen The serum concentration of Digoxin can be increased when it is combined with Ibuprofen.
Orphenadrine Orphenadrine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Orphenadrine.
Azathioprine Azathioprine Azathioprine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Amoxapine.
Sulfasalazine Sulfasalazine The serum concentration of Digoxin can be decreased when it is combined with Sulfasalazine.
Hydrocortisone Hydrocortisone The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Digoxin.
Doxorubicin Doxorubicin Digoxin may decrease the excretion rate of Doxorubicin which could result in a higher serum level.
Mechlorethamine Mechlorethamine Digoxin may decrease the cardiotoxic activities of Mechlorethamine.
Dactinomycin Dactinomycin The serum concentration of Digoxin can be increased when it is combined with Dactinomycin.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Carbamazepine Carbamazepine Digoxin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Methyldopa Methyldopa Methyldopa may decrease the excretion rate of Digoxin which could result in a higher serum level.
Clonidine Clonidine Clonidine may increase the atrioventricular blocking (AV block) activities of Digoxin.
Hydralazine Hydralazine Hydralazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection The serum concentration of Digoxin can be increased when it is combined with Gentamicin.
Warfarin Warfarin Digoxin may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam Clonazepam Clonazepam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loperamide Loperamide Loperamide may increase the arrhythmogenic activities of Digoxin.
Promethazine Promethazine Digoxin may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Daunorubicin Daunorubicin Digoxin may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine Loxapine Loxapine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine Digoxin may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Quinine Quinine The serum concentration of Digoxin can be increased when it is combined with Quinine.
Ethosuximide Ethosuximide Ethosuximide may increase the arrhythmogenic activities of Digoxin.
Calcitriol Calcitriol The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Calcitriol is combined with Digoxin.
Triamterene Triamterene Triamterene may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sulfinpyrazone Sulfinpyrazone Sulfinpyrazone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the hypokalemic activities of Digoxin.
Chlorthalidone Chlorthalidone The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.
Metolazone Metolazone Metolazone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection Clindamycin Injection The serum concentration of Digoxin can be increased when it is combined with Clindamycin.
Secobarbital Secobarbital Secobarbital may decrease the excretion rate of Digoxin which could result in a higher serum level.
Desipramine Desipramine Digoxin may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline Amitriptyline Amitriptyline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Imipramine Imipramine Digoxin may decrease the excretion rate of Imipramine which could result in a higher serum level.
Probenecid Probenecid Probenecid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Quinidine Quinidine The serum concentration of Digoxin can be increased when it is combined with Quinidine.
Procainamide Procainamide Digoxin may increase the arrhythmogenic activities of Procainamide.
Isoniazid Isoniazid Isoniazid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Rifampin Rifampin The serum concentration of Digoxin can be decreased when it is combined with Rifampicin.
Disopyramide Disopyramide Digoxin may increase the arrhythmogenic activities of Disopyramide.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Digoxin is combined with Valproic acid.
Tamoxifen Tamoxifen Tamoxifen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Mitomycin Mitomycin Digoxin may decrease the cardiotoxic activities of Mitomycin.
Butabarbital Butabarbital Butabarbital may decrease the excretion rate of Digoxin which could result in a higher serum level.
Levothyroxine Levothyroxine Levothyroxine may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Liothyronine Liothyronine The serum concentration of Liothyronine can be decreased when it is combined with Digoxin.
Methimazole Methimazole The serum concentration of Digoxin can be increased when it is combined with Methimazole.
Propylthiouracil Propylthiouracil The serum concentration of Digoxin can be increased when it is combined with Propylthiouracil.
Chlorpropamide Chlorpropamide Chlorpropamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tolbutamide Tolbutamide Tolbutamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tolazamide Tolazamide Tolazamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dinoprostone Dinoprostone The excretion of Dinoprostone can be decreased when combined with Digoxin.
Baclofen Baclofen Baclofen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Digoxin.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Cyproheptadine.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Dexbrompheniramine.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the hypokalemic activities of Digoxin.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may increase the hypokalemic activities of Digoxin.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Digoxin is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Disulfiram Disulfiram Disulfiram may decrease the excretion rate of Digoxin which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Propranolol may increase the arrhythmogenic activities of Digoxin.
Nortriptyline Nortriptyline The risk or severity of QTc prolongation can be increased when Digoxin is combined with Nortriptyline.
Spironolactone Spironolactone The serum concentration of Digoxin can be increased when it is combined with Spironolactone.
Amphotericin B Injection Amphotericin B Injection The risk or severity of adverse effects can be increased when Amphotericin B is combined with Digoxin.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nadolol Nadolol Nadolol may increase the arrhythmogenic activities of Digoxin.
Cholestyramine Resin Cholestyramine Resin The serum concentration of Digoxin can be decreased when it is combined with Cholestyramine.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Digoxin.
Clomiphene Clomiphene The serum concentration of Digoxin can be increased when it is combined with Clomifene.
Flavoxate Flavoxate Flavoxate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Digoxin is combined with Fluorouracil.
Colchicine Colchicine Colchicine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dacarbazine Dacarbazine Dacarbazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.
Nystatin Nystatin The excretion of Digoxin can be decreased when combined with Nystatin.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Digoxin which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ketoconazole Ketoconazole The serum concentration of Digoxin can be increased when it is combined with Ketoconazole.
Pyrantel Pyrantel Pyrantel may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vincristine Injection Vincristine Injection Vincristine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Captopril Captopril The serum concentration of Digoxin can be increased when it is combined with Captopril.
Dipyridamole Dipyridamole Dipyridamole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Vinblastine Vinblastine Vinblastine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ethacrynic Acid Ethacrynic Acid The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Digoxin.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Metoprolol Metoprolol Metoprolol may increase the arrhythmogenic activities of Digoxin.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Hydroxyzine.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Digoxin is combined with Thiothixene.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Alprazolam Alprazolam The serum concentration of Digoxin can be increased when it is combined with Alprazolam.
Temazepam Temazepam Temazepam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Triazolam Triazolam Triazolam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dicyclomine Dicyclomine Dicyclomine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Hyoscyamine Hyoscyamine Digoxin may increase the arrhythmogenic activities of Hyoscyamine.
Propantheline Propantheline The serum concentration of Digoxin can be increased when it is combined with Propantheline.
Trimethoprim Trimethoprim The serum concentration of Digoxin can be increased when it is combined with Trimethoprim.
Diltiazem Diltiazem The serum concentration of Digoxin can be increased when it is combined with Diltiazem.
Nifedipine Nifedipine The serum concentration of Digoxin can be increased when it is combined with Nifedipine.
Timolol Timolol Timolol may increase the arrhythmogenic activities of Digoxin.
Verapamil Verapamil The serum concentration of Digoxin can be increased when it is combined with Verapamil.
Atenolol Atenolol Atenolol may increase the arrhythmogenic activities of Digoxin.
Pindolol Pindolol Pindolol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection Cisplatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Digoxin which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Bumetanide Bumetanide The risk or severity of adverse effects can be increased when Bumetanide is combined with Digoxin.
Etoposide Etoposide The serum concentration of Digoxin can be increased when it is combined with Etoposide.
Glyburide Glyburide Glyburide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Glipizide Glipizide Glipizide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Indapamide Indapamide Indapamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amoxicillin Amoxicillin Amoxicillin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pentoxifylline may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Labetalol Labetalol Labetalol may decrease the excretion rate of Digoxin which could result in a higher serum level.
Auranofin Auranofin Auranofin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Gemfibrozil Gemfibrozil Gemfibrozil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pimozide Pimozide The risk or severity of QTc prolongation can be increased when Digoxin is combined with Pimozide.
Enalapril Enalapril The excretion of Enalapril can be decreased when combined with Digoxin.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Digoxin which could result in a higher serum level.
Amiodarone Amiodarone The serum concentration of Digoxin can be increased when it is combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Buspirone Buspirone Digoxin may decrease the excretion rate of Buspirone which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Diclofenac Diclofenac The serum concentration of Digoxin can be increased when it is combined with Diclofenac.
Fluoxetine Fluoxetine The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Digoxin.
Nimodipine Nimodipine Nimodipine may increase the arrhythmogenic activities of Digoxin.
Clozapine Clozapine Clozapine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Estazolam Estazolam Estazolam may decrease the excretion rate of Digoxin which could result in a higher serum level.
Idarubicin Idarubicin Digoxin may decrease the cardiotoxic activities of Idarubicin.
Ofloxacin Ofloxacin Ofloxacin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Didanosine Didanosine Didanosine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection Digoxin may decrease the cardiotoxic activities of Fludarabine.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Clarithromycin Clarithromycin The serum concentration of Digoxin can be increased when it is combined with Clarithromycin.
Benazepril Benazepril The risk or severity of hyperkalemia can be increased when Digoxin is combined with Benazepril.
Etodolac Etodolac Etodolac may decrease the excretion rate of Digoxin which could result in a higher serum level.
Felodipine Felodipine Felodipine may increase the arrhythmogenic activities of Digoxin.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Quinapril Quinapril The risk or severity of hyperkalemia can be increased when Digoxin is combined with Quinapril.
Ramipril Ramipril The risk or severity of hyperkalemia can be increased when Ramipril is combined with Digoxin.
Simvastatin Simvastatin The serum concentration of Digoxin can be increased when it is combined with Simvastatin.
Amlodipine Amlodipine Amlodipine may increase the arrhythmogenic activities of Digoxin.
Teniposide Injection Teniposide Injection Digoxin may decrease the cardiotoxic activities of Teniposide.
Itraconazole Itraconazole The serum concentration of Digoxin can be increased when it is combined with Itraconazole.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Digoxin which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sotalol Sotalol Sotalol may increase the arrhythmogenic activities of Digoxin.
Bisoprolol Bisoprolol The therapeutic efficacy of Digoxin can be increased when used in combination with Bisoprolol.
Isradipine Isradipine Isradipine may increase the arrhythmogenic activities of Digoxin.
Omeprazole Omeprazole The serum concentration of Digoxin can be increased when it is combined with Omeprazole.
Cisapride Cisapride The risk or severity of QTc prolongation can be increased when Digoxin is combined with Cisapride.
Fluvastatin Fluvastatin The excretion of Fluvastatin can be decreased when combined with Digoxin.
Venlafaxine Venlafaxine Venlafaxine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nefazodone Nefazodone The serum concentration of Digoxin can be increased when it is combined with Nefazodone.
Lamotrigine Lamotrigine Lamotrigine may increase the arrhythmogenic activities of Digoxin.
Losartan Losartan Losartan may increase the arrhythmogenic activities of Digoxin.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tramadol Tramadol The risk or severity of adverse effects can be increased when Tramadol is combined with Digoxin.
Vinorelbine Injection Vinorelbine Injection Digoxin may decrease the cardiotoxic activities of Vinorelbine.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Digoxin is combined with Moexipril.
Lansoprazole Lansoprazole The serum concentration of Digoxin can be increased when it is combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection Ifosfamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nicardipine Nicardipine Nicardipine may increase the arrhythmogenic activities of Digoxin.
Bupropion Bupropion Bupropion may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ticlopidine Ticlopidine Ticlopidine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Saquinavir Saquinavir The serum concentration of Digoxin can be increased when it is combined with Saquinavir.
Metformin Metformin The serum concentration of Digoxin can be increased when it is combined with Metformin.
Dalteparin Injection Dalteparin Injection The risk or severity of hyperkalemia can be increased when Digoxin is combined with Dalteparin.
Nisoldipine Nisoldipine Nisoldipine may increase the arrhythmogenic activities of Digoxin.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Acarbose Acarbose The serum concentration of Digoxin can be decreased when it is combined with Acarbose.
Glimepiride Glimepiride Glimepiride may increase the arrhythmogenic activities of Digoxin.
Anastrozole Anastrozole Digoxin may decrease the cardiotoxic activities of Anastrozole.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Indinavir Indinavir Indinavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Ritonavir Ritonavir The bioavailability of Digoxin can be increased when combined with Ritonavir.
Docetaxel Injection Docetaxel Injection Digoxin may decrease the cardiotoxic activities of Docetaxel.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Digoxin which could result in a higher serum level.
Clomipramine Clomipramine Digoxin may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Digoxin.
Trandolapril Trandolapril The risk or severity of hyperkalemia can be increased when Digoxin is combined with Trandolapril.
Topiramate Topiramate Topiramate may decrease the excretion rate of Digoxin which could result in a higher serum level.
Valsartan Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Digoxin.
Pramipexole Pramipexole Pramipexole may decrease the excretion rate of Digoxin which could result in a higher serum level.
Donepezil Donepezil Digoxin may increase the bradycardic activities of Donepezil.
Nelfinavir Nelfinavir Nelfinavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Fexofenadine Fexofenadine The serum concentration of Digoxin can be increased when it is combined with Fexofenadine.
Azithromycin Azithromycin The serum concentration of Digoxin can be increased when it is combined with Azithromycin.
Loratadine Loratadine Loratadine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Carvedilol Carvedilol The serum concentration of Digoxin can be increased when it is combined with Carvedilol.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Flutamide Flutamide Flutamide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Propafenone Propafenone The serum concentration of Digoxin can be increased when it is combined with Propafenone.
Raloxifene Raloxifene The excretion of Raloxifene can be decreased when combined with Digoxin.
Irbesartan Irbesartan The risk or severity of hyperkalemia can be increased when Digoxin is combined with Irbesartan.
Tamsulosin Tamsulosin Tamsulosin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Quetiapine Quetiapine Digoxin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Digoxin which could result in a higher serum level.
Cetirizine Cetirizine Cetirizine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Digoxin is combined with Citalopram.
Capecitabine Capecitabine Capecitabine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Efavirenz Efavirenz Efavirenz may decrease the excretion rate of Digoxin which could result in a higher serum level.
Abacavir Abacavir Abacavir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Sildenafil Sildenafil Sildenafil may decrease the excretion rate of Digoxin which could result in a higher serum level.
Trastuzumab Injection Trastuzumab Injection Digoxin may decrease the cardiotoxic activities of Trastuzumab.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Rosiglitazone Rosiglitazone Rosiglitazone may decrease the excretion rate of Digoxin which could result in a higher serum level.
Tolterodine Tolterodine Tolterodine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Thalidomide Thalidomide Digoxin may decrease the cardiotoxic activities of Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Digoxin which could result in a higher serum level.
Aluminum Hydroxide Aluminum Hydroxide The serum concentration of Digoxin can be decreased when it is combined with Aluminum hydroxide.
Colesevelam Colesevelam Colesevelam can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Nateglinide Nateglinide Nateglinide may decrease the excretion rate of Digoxin which could result in a higher serum level.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Digoxin is combined with Galantamine.
Rabeprazole Rabeprazole The serum concentration of Digoxin can be increased when it is combined with Rabeprazole.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists